In the realm of fine chemicals and pharmaceutical intermediates, compounds with specific structural features are highly sought after for their utility in complex syntheses. 2-Bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one, bearing the CAS number 283173-80-8, is one such compound that plays a pivotal role. Ningbo Inno Pharmchem Co., Ltd. is dedicated to shedding light on the synthesis and diverse applications of this important chemical entity.

The synthesis of 2-Bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one typically involves established organic chemistry methodologies. The provided source material indicates a synthesis route starting from 8-fluoro-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one, undergoing a bromination reaction using pyridinium tribromide. This process, often carried out under controlled temperature conditions, yields the target compound with high purity. The meticulous execution of such chemical synthesis pathways is crucial for producing intermediates that meet the stringent quality standards of the pharmaceutical sector. Understanding these synthesis processes is key for researchers looking to optimize their own workflows.

Beyond its role as a Rucaparib intermediate, this compound serves as a valuable chemical building block for a range of pharmaceutical intermediates and fine chemical applications. Its unique heterocyclic structure, coupled with the presence of halogen substituents, allows for a variety of subsequent chemical transformations. These transformations can lead to the development of new APIs with enhanced therapeutic properties or the creation of specialized materials. For those seeking to purchase these essential reagents, exploring the various buy options and understanding the typical price points for high-purity compounds is a common practice in research procurement.

Ningbo Inno Pharmchem Co., Ltd. emphasizes the importance of reliable sourcing for chemical synthesis projects. The availability of 2-Bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one from multiple manufacturers underscores its established presence in the chemical supply chain. Researchers engaged in drug discovery or process development can benefit from this accessibility, ensuring that their experiments and production cycles are not hindered by material shortages. This continuous access to critical components is fundamental to driving progress in the pharmaceutical and fine chemical industries.

In conclusion, 2-Bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one represents more than just a chemical formula; it is a vital link in the chain of innovation within the pharmaceutical industry. Its role as a Rucaparib intermediate and its potential in broader organic synthesis highlight its value. Ningbo Inno Pharmchem Co., Ltd. remains committed to supporting scientific advancement by facilitating access to such indispensable chemical building blocks.